| 08/08/25 | 07:00:02 | 8 Aug 2025 | | Cancellation - Celadon Pharmaceuticals Plc |
| 05/08/25 | 18:00:00 | 5 Aug 2025 | | Celadon Pharmaceuticals |
| 28/07/25 | 16:10:33 | 28 Jul 2025 | | Result of General Meeting |
| 02/07/25 | 07:00:06 | 2 Jul 2025 | | Proposed Cancellation |
| 01/07/25 | 11:48:57 | 1 Jul 2025 | | Funding Update |
| 01/07/25 | 08:20:33 | 1 Jul 2025 | | Result of AGM |
| 01/07/25 | 07:30:00 | 1 Jul 2025 | | Suspension - Celadon Pharmaceuticals Plc |
| 30/06/25 | 07:00:12 | 30 Jun 2025 | | Funding and Operational Update, Delay in Results |
| 11/06/25 | 07:00:07 | 11 Jun 2025 | | New Committed Credit Facility |
| 06/06/25 | 15:55:44 | 6 Jun 2025 | | Funding Update, Notice of AGM |
| 30/05/25 | 18:07:50 | 30 May 2025 | | Funding Update |
| 30/04/25 | 07:00:03 | 30 Apr 2025 | | Funding Update |
| 08/04/25 | 15:05:14 | 8 Apr 2025 | | Termination of Facility |
| 31/03/25 | 15:15:01 | 31 Mar 2025 | | Funding Update |
| 24/03/25 | 07:00:11 | 24 Mar 2025 | | Board Changes and De-Listing Proposal |
| 19/03/25 | 07:00:07 | 19 Mar 2025 | | Funding Update |
| 26/02/25 | 13:00:01 | 26 Feb 2025 | | New Committed Credit Facility |
| 12/02/25 | 07:00:04 | 12 Feb 2025 | | Finance Update |
| 31/01/25 | 07:00:05 | 31 Jan 2025 | | Finance Update |
| 16/01/25 | 07:00:01 | 16 Jan 2025 | | Update on Strategic Collaboration |
| 02/01/25 | 07:00:06 | 2 Jan 2025 | | Funding Update |
| 20/12/24 | 07:00:07 | 20 Dec 2024 | | Finance Update |
| 06/12/24 | 07:00:05 | 6 Dec 2024 | | Receipt of Subscription Proceeds |
| 18/11/24 | 07:00:05 | 18 Nov 2024 | | Update on Financial Position |
| 04/10/24 | 13:00:01 | 4 Oct 2024 | | Investor Site Visit – Tuesday 22 October 2024 |
| 02/10/24 | 07:00:02 | 2 Oct 2024 | | New Sales Contract with a Healthcare Company |
| 30/09/24 | 07:05:00 | 30 Sept 2024 | | Departure of Chief Financial Officer |
| 30/09/24 | 07:00:10 | 30 Sept 2024 | | Interim Results |
| 17/09/24 | 09:28:59 | 17 Sept 2024 | | Admission of Shares and Total Voting Rights |
| 11/09/24 | 07:05:00 | 11 Sept 2024 | | Equity Fundraise and Update on Financial Position |
| 11/09/24 | 07:00:08 | 11 Sept 2024 | | Strategic collaboration with Valeos |
| 23/08/24 | 07:00:05 | 23 Aug 2024 | | Update on Financial Position |
| 12/08/24 | 07:00:06 | 12 Aug 2024 | | Update on Operations and Financial Position |
| 16/07/24 | 07:00:06 | 16 Jul 2024 | | Successful Completion of Eighth Harvest of 2024 |
| 15/07/24 | 13:58:13 | 15 Jul 2024 | | Third Admission of Shares |
| 28/06/24 | 07:00:11 | 28 Jun 2024 | | Result of AGM |
| 07/06/24 | 07:00:07 | 7 Jun 2024 | | Second Admission of Shares |
| 03/06/24 | 17:45:01 | 3 Jun 2024 | | Publication of Annual Report & Notice of AGM |
| 23/05/24 | 07:00:13 | 23 May 2024 | | Supply of Products to New US Customer |
| 15/05/24 | 14:45:01 | 15 May 2024 | | Exercise of Share Options and Total Voting Rights |
| 14/05/24 | 07:00:12 | 14 May 2024 | | Final Results |
| 10/05/24 | 07:00:08 | 10 May 2024 | | Fundraise, RCF Extension, Termination of CLN & TVR |
| 07/03/24 | 07:00:13 | 7 Mar 2024 | | Early Economic Analysis of Feasibility Study Data |
| 14/12/23 | 07:00:09 | 14 Dec 2023 | | Product Supplied to First Two Sales Contracts |
| 12/12/23 | 14:00:01 | 12 Dec 2023 | | Fundraise, Update on Future CLN Financing & TVR |
| 16/11/23 | 07:00:10 | 16 Nov 2023 | | New European Sales Contract |
| 13/10/23 | 07:00:07 | 13 Oct 2023 | | Fundraise, CLN Issue, Joint Broker Appointed & TVR |
| 28/09/23 | 07:00:07 | 28 Sept 2023 | | Interim Results |
| 18/09/23 | 07:00:06 | 18 Sept 2023 | | Notice of Results and Investor Presentation |
| 05/09/23 | 07:00:03 | 5 Sept 2023 | | New Sales Contract with UK Pharmaceutical Company |
